GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Aytu BioPharma Inc.
Aytu BioPharma is a diversified pharmaceutical company. Its stock price reflects its growth strategy through acquisitions and commercialization of various products. The chart is a history of portfolio management and the search for synergies between different assets.
Share prices of companies in the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company that commercializes a portfolio of prescription drugs for the treatment of various diseases. We classify it as a "Specialty Pharmaceutical." The chart below shows how investors value companies focused on sales rather than drug development.
Broad Market Index - GURU.Markets
Aytu BioPharma is a diversified pharmaceutical company that commercializes a portfolio of prescription drugs and consumer healthcare products. As a unique player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Aytu's performance.
Change in the price of a company, segment, and market as a whole per day
AYTU - Daily change in the company's share price Aytu BioPharma Inc.
For Aytu BioPharma, Inc., a pharmaceutical company with a diversified portfolio, daily volatility reflects sensitivity to sales data and R&D news. This metric is an important element of analysis in this sector.
Daily change in the price of a set of shares in a market segment - Specialized pharma
Aytu BioPharma, Inc. is a pharmaceutical company. This chart shows the sector's high volatility. Comparing it to AYTU's performance, with its diversified portfolio, helps assess how this impacts its stability.
Daily change in the price of a broad market stock, index - GURU.Markets
Aytu BioPharma is a pharmaceutical company with a diversified product portfolio. Its shares react to news across numerous commercial and clinical programs. This complex, multi-factor dynamic contributes uniquely to the overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Aytu BioPharma Inc.
Aytu BioPharma's year-over-year performance tells the story of its transformation into a diversified pharmaceutical company. Its market capitalization over the past 12 months reflects its success in selling its prescription drugs, as well as progress in clinical trials of its new candidates, which is key to its strategy for building a sustainable business.
Annual dynamics of market capitalization of the market segment - Specialized pharma
Aytu BioPharma, Inc. is a specialty pharmaceutical company. Its complex structure and acquisition strategy make it a unique player. This chart shows how the market evaluates its ability to generate value from diverse assets and commercialize its niche products.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aytu BioPharma, a commercial pharmaceutical company, uses its sales force dynamics to determine its effectiveness. Unlike biotech companies in the development stage, revenue from approved drugs is crucial. Market outperformance indicates successful marketing and market share growth, while lagging indicates challenges with commercialization.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Aytu BioPharma Inc.
Aytu BioPharma is a diversified pharmaceutical company. Its monthly performance is the sum of its various product indicators. Quarterly sales reports for its prescription drugs and progress in clinical development are the primary drivers of its valuation.
Monthly dynamics of market capitalization of the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of new drugs for the treatment of rare diseases and conditions requiring special attention. The graph below illustrates the overall dynamics of the pharmaceutical sector, where Aytu is attempting to carve out a niche by bringing existing products to market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Aytu BioPharma is a pharmaceutical company with a portfolio of commercial products and drugs in development. Its dynamics are a mixture of stability from current sales and volatility from clinical trial news. This creates a complex correlation with the market, where the company can move both with and against it.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products to address unmet medical needs. Its weekly stock price is driven by the success of its drug sales and clinical trial results.
Weekly dynamics of market capitalization of the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company with a diversified portfolio. This chart helps understand how its weekly stock performance compares to its sector. Does diversification smooth out volatility compared to competitors, or do specific products create their own unique movements?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Aytu BioPharma is a pharmaceutical company whose stock follows the rhythm of clinical trial and drug sales news. The chart clearly shows how its weekly performance is detached from the broader market, moving along its own unique trajectory.
Market capitalization of the company, segment and market as a whole
AYTU - Market capitalization of the company Aytu BioPharma Inc.
Aytu BioPharma's market capitalization is a visual representation of the complexities of the pharmaceutical business. This company, which has a diverse portfolio of prescription drugs, shows how the market perceives its ability to grow sales of existing products and the risks associated with developing new ones.
AYTU - Share of the company's market capitalization Aytu BioPharma Inc. within the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company focused on commercializing products to address significant unmet medical needs. In the specialty pharmaceuticals segment, its market capitalization reflects its product portfolio and ability to market them effectively. A company's market capitalization is an indicator of the success of its commercial strategy.
Market capitalization of the market segment - Specialized pharma
Aytu BioPharma is a diversified pharmaceutical company. What is the size of this industry? The chart below shows the overall market capitalization of the specialized pharmaceutical sector. Its dynamics reflect how investors value companies with a broad product portfolio targeting various therapeutic areas.
Market capitalization of all companies included in a broad market index - GURU.Markets
The Aytu BioPharma chart tells the story of a diversified pharmaceutical company operating in the prescription drug market. Its market capitalization reflects the value of its product portfolio and the company's ability to effectively market them. This diagram highlights the challenges and opportunities of a small player in big pharma.
Book value capitalization of the company, segment and market as a whole
AYTU - Book value capitalization of the company Aytu BioPharma Inc.
For Aytu BioPharma, a company specializing in the commercialization of pharmaceutical products, book value represents its tangible assets: drug rights, product inventory, and commercial infrastructure. The chart below shows how the value of this sales-oriented tangible foundation has changed.
AYTU - Share of the company's book capitalization Aytu BioPharma Inc. within the market segment - Specialized pharma
Aytu BioPharma, Inc. is a pharmaceutical company whose assets include manufacturing facilities for its prescription drugs and distribution centers for their distribution. The chart shows the share of this commercial pharmaceutical infrastructure the company controls in its therapeutic areas.
Market segment balance sheet capitalization - Specialized pharma
Aytu BioPharma is a pharmaceutical company. The pharmaceutical industry, as the graph shows, is both knowledge- and capital-intensive. Aytu, as a commercial company, invests not only in R&D but also in the infrastructure for marketing its products.
Book value of all companies included in the broad market index - GURU.Markets
Aytu BioPharma's assets comprise a diversified portfolio, encompassing both the sale of prescription medications for adults and children, as well as the development of new drugs. Its book value reflects its commercial infrastructure, inventory, and R&D capital. The chart illustrates its scale.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company that markets a portfolio of approved drugs. Its value lies not in R&D, but in the cash flows from these products. The chart shows how the market views its commercial strategy and the stability of revenue from this diversified drug portfolio.
Market to book capitalization ratio in a market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of unique drugs. Its valuation is determined by sales success and its product portfolio. The chart shows how the market views its commercial strategy and growth potential relative to its book value.
Market to book capitalization ratio for the market as a whole
Aytu BioPharma is a pharmaceutical company with a portfolio of commercialized products. Its valuation includes the value of inventory and production, as well as intangible assets such as patents and trademarks. This chart helps understand how the market balances the valuation of actual sales with the potential for future developments.
Debts of the company, segment and market as a whole
AYTU - Company debts Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company that commercializes and markets approved drugs. Unlike R&D companies, Aytu can use debt to acquire rights to new products, finance marketing campaigns to promote its drugs, and manage working capital to maintain inventory.
Market segment debts - Specialized pharma
Aytu BioPharma is a pharmaceutical company with a portfolio of commercial products focused on various therapeutic areas. Unlike R&D-stage biotechs, Aytu generates revenue but also incurs marketing and distribution expenses. This chart shows how the company balances sales of existing products with the development of new ones.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company selling a range of prescription drugs. This chart shows its financial structure. For a company that grows, in part, through the acquisition of rights to new drugs, debt is a tool. However, it's important for investors to evaluate whether the acquired products generate sufficient cash flow to service the debt.
Market segment debt to market segment book capitalization - Specialized pharma
Aytu BioPharma is a specialty pharmaceutical company focused on commercializing products to address unmet medical needs. Its business model may include acquiring rights to drugs. The chart shows the overall debt burden in the pharmaceutical industry, which helps assess how the company finances its product portfolio.
Debt to book value of all companies in the market
Aytu BioPharma is a pharmaceutical company selling a range of prescription drugs. Unlike R&D-stage biotechs, Aytu has revenue, but it can use debt for marketing or acquiring new products. This chart provides context for assessing how aggressively the company uses leverage to grow its commercial portfolio.
P/E of the company, segment and market as a whole
P/E - Aytu BioPharma Inc.
This chart for Aytu BioPharma, a specialty pharmaceutical company, shows the valuation of its commercial product portfolio. The P/E ratio reflects current sales and the company's ability to grow them. It's an assessment not so much of future breakthroughs as of the effectiveness of its commercial team and the demand for existing drugs.
P/E of the market segment - Specialized pharma
Aytu BioPharma is a specialty pharmaceutical company focused on commercializing new products to treat diseases with unmet medical needs. This chart shows the average valuation for the sector, providing investors with context for evaluating Aytu's portfolio and commercial strategy.
P/E of the market as a whole
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for niche markets. Its valuation is based less on a scientific breakthrough than on its ability to effectively market existing or acquired drugs. This sentiment graph indirectly impacts the company, but for Aytu, its commercial strategy and execution are more important.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Aytu BioPharma Inc.
Aytu BioPharma is a specialty pharmaceutical company focused on commercializing products for pediatrics and other niche markets. This chart reflects sales expectations for its pipeline. Future profitability depends on successful marketing of existing products and the acquisition of new promising assets.
%20P%2FE%20Aytu%20BioPharma%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Aytu-BioPharma-Inc.&v=1772637770636 "Chart of the company's future (projected) P/E Aytu BioPharma Inc.")
Future (projected) P/E of the market segment - Specialized pharma
Aytu BioPharma is a specialty pharmaceutical company focused on commercializing products to address significant unmet patient needs. Its valuation relative to other pharmaceutical companies reflects the market's perception of its product portfolio and acquisition-led growth strategy. This reflects confidence in its commercial team.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20pharma&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-pharma&v=1772637770638 "Future (projected) P/E graph of the market segment - Specialized pharma")
Future (projected) P/E of the market as a whole
Aytu BioPharma is a pharmaceutical company selling a range of prescription drugs and consumer healthcare products. Its strategy includes both selling existing products and developing new ones. This chart shows the overall sentiment in the healthcare market that influences the valuation of diversified pharmaceutical companies that are not pure biotech startups.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772637770640 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Aytu BioPharma Inc.
Aytu BioPharma is a specialty pharmaceutical company focused on commercializing products to address significant medical unmet medical needs. Its financial results, presented here, are dependent on successful sales of its existing pipeline and the acquisition of new promising assets.
Profit of companies in the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for the treatment of various diseases. This chart reflects the overall profitability of the specialty pharmaceutical sector. It helps understand the potential success of a strategy to acquire and commercialize existing or late-stage development pipelines.
Overall market profit
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products across various therapeutic areas. Its success depends on its ability to effectively market its existing drugs and introduce new ones. This business is less dependent on general economic cycles and more dependent on the specifics of the healthcare market and competition.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for the treatment of various diseases. Its future profitability depends on the successful sales of its current drug portfolio and its ability to acquire or develop new products. This chart reflects analyst revenue expectations for the company's key drugs.
%20profit%20of%20the%20company%20Aytu%20BioPharma%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Aytu-BioPharma-Inc.&v=1772637770647 "Graph of future (projected) profit of the company Aytu BioPharma Inc.")
Future (predicted) profit of companies in the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company that commercializes a portfolio of prescription drugs and consumer healthcare products, often acquiring already approved products. This chart shows forecasts for the specialty pharmaceutical industry. It allows one to assess how the company's strategy, focused on commercialization rather than R&D, aligns with overall industry trends.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20pharma&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-pharma&v=1772637770657 "Graph of future (predicted) profits of companies in a market segment - Specialized pharma")
Future (predicted) profit of the market as a whole
For Aytu BioPharma, a company operating in the specialty pharmaceuticals niche, this schedule is important from an investment climate perspective. Positive economic expectations facilitate raising capital for product commercialization and research. A recession can make investors more cautious, which could hinder financing and slow the company's growth.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772637770663 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company selling a range of prescription drugs. This chart shows how the market values its current sales revenue. It reflects the effectiveness of its commercial strategy and the potential of its products in development.
P/S market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company focused on commercializing products for the treatment of serious diseases. This chart shows the average valuation in the specialty pharmaceuticals sector. It helps understand how investors view Aytu's product portfolio, its commercial strategy, and the revenue growth potential of its current and future products.
P/S of the market as a whole
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing products for the treatment of rare diseases and conditions with unmet medical needs. The company's revenue is generated from the sale of approved drugs. This chart helps assess the market's valuation of a commercial pharmaceutical company with a diversified portfolio.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for the treatment of rare diseases and conditions with unmet needs. Future revenue depends on the successful sales of its drug portfolio. The chart reflects the market's assessment of its commercial strategy and revenue growth potential.
%20P%2FS%20Aytu%20BioPharma%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Aytu-BioPharma-Inc.&v=1772637770676 "The graph of the company's future (projected) P/S Aytu BioPharma Inc.")
Future (projected) P/S of the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for the treatment of serious diseases, often for small patient groups. Its portfolio includes pediatric and rare disease drugs. This chart shows how the market views its strategy for acquiring and marketing niche drugs.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20pharma&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-pharma&v=1772637770677 "Future (projected) P/S market segment graph - Specialized pharma")
Future (projected) P/S of the market as a whole
This chart shows general expectations for the specialty pharmaceutical market. For Aytu BioPharma, a company with a diversified portfolio of prescription drugs, this indicates the stability of the healthcare system. Market optimism supports the ability of patients and insurance companies to pay for treatment, ensuring stable demand for its products.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772637770701 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for the treatment of niche diseases. This chart shows sales revenue from its portfolio of prescription drugs and consumer healthcare products. Sales growth depends on the effectiveness of marketing efforts and the successful launch of new or acquired products.
Sales of companies in the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products to address significant medical needs. This chart shows the dynamics of the specialty pharmaceutical sector. Aytu's business model involves acquiring and commercializing existing drugs, allowing it to occupy various therapeutic niches.
Overall market sales
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing products to address unmet medical needs. Its revenue depends on successful sales and marketing. The overall economic environment, shown in this chart, impacts healthcare costs and the availability of its products to patients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for niche markets, including drugs for rare diseases and over-the-counter (OTC) products. Its revenue depends on successful sales of its existing portfolio. This chart shows analyst forecasts for demand for the company's products and the effectiveness of its commercial strategy.
%20sales%20of%20the%20company%20Aytu%20BioPharma%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Aytu-BioPharma-Inc.&v=1772637770769 "Schedule of future (projected) sales of the company Aytu BioPharma Inc.")
Future (projected) sales of companies in the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company focused on commercializing unique drugs to address significant unmet medical needs. This chart illustrates expectations for the entire specialty pharmaceutical sector, providing context for assessing Aytu's market strategy.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20pharma&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-pharma&v=1772637770779 "Schedule of future (projected) sales of companies in the market segment - Specialized pharma")
Future (projected) sales of the market as a whole
Aytu BioPharma, Inc. is a pharmaceutical company specializing in the commercialization of new products for the treatment of significant diseases. Its success depends on the effectiveness of sales and the launch of new drugs. The overall economic situation, reflected in this chart, affects healthcare budgets and patients' ability to afford prescription drugs.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772637770795 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for niche markets. This chart shows the profitability of its business model. Profit depends on successful sales of its portfolio of approved drugs and the ability to acquire or license new promising drugs to expand its business.
Market segment marginality - Specialized pharma
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of unique prescription drugs. Profitability depends on marketing strategy and sales effectiveness. This chart shows the average profitability in the specialty pharmaceutical industry, allowing one to assess how successfully Aytu BioPharma is promoting its products on the market.
Market marginality as a whole
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products across various therapeutic areas. This overall market profitability graph indirectly impacts the company through the healthcare system. However, its margins are more dependent on the success of its drug promotion, the competitive environment, and insurance reimbursement conditions.
Employees in the company, segment and market as a whole
Number of employees in the company Aytu BioPharma Inc.
Aytu BioPharma is a pharmaceutical company that markets a range of prescription drugs. This chart shows its commercial and scientific teams. Headcount reflects efforts to market existing products and develop or acquire new assets to expand the portfolio.
Share of the company's employees Aytu BioPharma Inc. within the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company focused on commercializing products to address unmet medical needs. This chart shows the percentage of sales, marketing, and regulatory affairs professionals the company employs in its niche. It reflects its operational scale and ability to bring new drugs to market.
Number of employees in the market segment - Specialized pharma
Aytu BioPharma is a specialty pharmaceutical company focused on commercializing products for rare diseases. This chart illustrates the diverse business models within the pharmaceutical industry: some companies focus on R&D, while others, like Aytu, focus on bringing existing drugs to patients, which requires a strong marketing and sales team.
Number of employees in the market as a whole
Aytu BioPharma, a specialist pharmaceutical company, is part of the vast healthcare industry. This chart demonstrates the scale of the labor market, where healthcare is one of the largest and most stable employers. Aytu's efforts to bring new drugs to market directly contribute to the growth of this vital sector.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Aytu BioPharma Inc. (AYTU)
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for rare diseases. This chart reflects the value of its "intellectual capital." The company's assets are not its manufacturing plants, but rather its licenses and rights to market approved or developed drugs. The chart shows the market value of this portfolio of commercial rights per employee.
%20of%20the%20company%20Aytu%20BioPharma%20Inc.%20(AYTU)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Aytu-BioPharma-Inc.-AYTU&v=1772637770891 "Chart of market capitalization per employee (in thousands of dollars) of the company Aytu BioPharma Inc. (AYTU)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized pharma
Aytu BioPharma commercializes pharmaceuticals. Their business model requires an effective sales, marketing, and regulatory affairs team. This chart reflects how the market evaluates this team's revenue-generating capacity. It allows for a comparison of their commercial performance with other pharmaceutical companies of similar size.
%20by%20market%20segment%20-%20Specialized%20pharma&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-pharma&v=1772637770896 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized pharma")
Market capitalization per employee (in thousands of dollars) for the overall market
Aytu BioPharma, Inc. is a specialty pharmaceutical company focused on the commercialization of new products. This chart shows the average market value generated by one specialist. It helps evaluate a business model focused on marketing and sales in the pharmaceutical industry.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772637770897 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Aytu BioPharma Inc. (AYTU)
Aytu BioPharma is a pharmaceutical company with a portfolio of commercial products. Unlike R&D firms, Aytu generates revenue. This chart shows how effectively their sales and manufacturing teams generate profit. It reflects the profitability of their drugs and the success of their commercial strategy.
%20Chart%20Aytu%20BioPharma%20Inc.%20(AYTU)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Aytu-BioPharma-Inc.-AYTU&v=1772637770900 "Company Profit Per Employee (in thousands of dollars) Chart Aytu BioPharma Inc. (AYTU)")
Profit per employee (in thousands of dollars) in the market segment - Specialized pharma
Aytu BioPharma is a pharmaceutical company that commercializes approved drugs and develops new ones. Its business model combines marketing and sales with scientific research. This chart allows us to assess how effectively the commercial division generates revenue from current products, which in turn funds the research team working on future drugs.
%20in%20the%20market%20segment%20-%20Specialized%20pharma&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-pharma&v=1772637770909 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized pharma")
Profit per employee (in thousands of dollars) for the market as a whole
Aytu BioPharma (AYTU) is a biopharmaceutical company that commercializes a portfolio of prescription (Rx) and consumer healthcare products, primarily for pediatrics and rare diseases. This chart shows the market average profitability per employee. It helps assess how effectively AYTU utilizes its commercial and R&D staff to generate revenue from its product portfolio.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772637770917 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Aytu BioPharma Inc. (AYTU)
Aytu BioPharma is a specialized pharmaceutical company selling a range of prescription drugs. This chart shows the performance of a commercial pharmaceutical company. It reflects how successfully the sales and marketing team promotes the company's products to doctors, turning them into a stable revenue stream.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Aytu-BioPharma-Inc.-AYTU&v=1772637770928 "Sales chart per company employee Aytu BioPharma Inc. (AYTU)")
Sales per employee in the market segment - Specialized pharma
Aytu BioPharma is a commercial pharmaceutical company focused on niche drugs and over-the-counter products. This chart shows the average revenue per employee in this segment. It allows us to assess how productive Aytu's team (R&D and commercialization) is in these highly specialized niches compared to other pharmaceutical companies.
Sales per employee for the market as a whole
Aytu BioPharma is a pharmaceutical company specializing in the commercialization of products for niche markets (e.g., pediatrics, rare diseases). This chart shows how productive their team is. For Aytu, it reflects the effectiveness of their commercial structure in promoting and selling their portfolio of approved drugs.
Short shares by company, segment and market as a whole
Shares shorted by company Aytu BioPharma Inc. (AYTU)
Aytu BioPharma is a microcap holding company with a diverse portfolio of pharmaceutical products (from ADHD to over-the-counter medications). The company is struggling with losses and high debt. This chart shows the bets that this hodgepodge is unviable. Bears believe the company has no blockbusters and will burn through its remaining capital.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Aytu-BioPharma-Inc.-AYTU&v=1772637770964 "Short Shares Chart for the Company Aytu BioPharma Inc. (AYTU)")
Shares shorted by market segment - Specialized pharma
Aytu BioPharma, Inc. is a specialty pharmaceutical company selling a portfolio of prescription drugs, including those for attention deficit and rare diseases. This indicator reflects the overall volume of short positions in the pharmaceutical sector. An increase in short positions here may indicate that investors perceive risks of pricing pressure or generic competition for the entire industry.
Shares shorted by the overall market
Aytu BioPharma is a pharmaceutical company with a diverse product portfolio (including vitamins). This chart illustrates the overall market pessimism. Investors see a hodgepodge of assets and fear the company lacks a clear focus and that demand for its non-essential products (dietary supplements) will decline during a recession.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Aytu BioPharma Inc. (AYTU)
This chart for Aytu BioPharma is an indicator of the struggle for survival in the "specialty" pharmaceutical industry. The company sells a number of niche drugs (including ADHD) and vitamins. "Overheating" (above 70) occurs on news of rising sales of its key drug. However, high debt, competition from generics, and a constant need for capital lead to "oversold" (below 30).
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Aytu-BioPharma-Inc.-AYTU&v=1772637770999 "RSI 14 indicator chart for the company's stock Aytu BioPharma Inc. (AYTU)")
RSI 14 Market Segment - Specialized pharma
Aytu BioPharma (AYTU) is a "specialized" pharma company. They don't *do* R&D, but *commercialize* (sell) *niche* branded drugs (for *pediatrics*, *cough*). The "specialized pharma" sector lives on "cycles." RSI_14_Seg shows the "temperature" of the *entire* industry. It helps us understand: is AYTU's growth a "niche" or a "general" hype?
RSI 14 for the overall market
Aytu BioPharma (AYTU) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast AYTU (Aytu BioPharma Inc.)
Aytu BioPharma is a specialty pharmaceutical company focused on commercializing niche drugs for the treatment of rare diseases and sleep disorders. This chart shows the average 12-month forecast of analysts. It reflects their view on the commercial success of the current pipeline and the risks associated with R&D.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-AYTU-Aytu-BioPharma-Inc.&v=1772637771054 "A chart showing analyst consensus forecasts for the expected stock price. AYTU (Aytu BioPharma Inc.)")
The difference between the consensus estimate and the actual stock price AYTU (Aytu BioPharma Inc.)
Aytu BioPharma is a niche pharmaceutical company focused on commercializing products for ADHD and rare diseases. This chart measures the gap between the current price and the consensus target price. It shows how confident experts are in their ability to grow sales of existing drugs and develop their R&D portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-AYTU-Aytu-BioPharma-Inc.&v=1772637771060 "A chart showing the difference between the consensus forecast and the actual stock price. AYTU (Aytu BioPharma Inc.)")
Analyst consensus forecast for stock prices by market segment - Specialized pharma
Aytu BioPharma is a micro-cap pharmaceutical company that strives to combine R&D and commercialization of niche drugs. This chart reflects analysts' overall expectations for the entire specialty pharma sector. It shows whether experts believe in the success of junior biotechs or consider the sector too risky.
Analysts' consensus forecast for the overall market share price
Aytu BioPharma is a specialty pharmaceutical company that commercializes (sells) a portfolio of niche drugs, including those for ADHD. This chart shows overall market sentiment. For Aytu, which operates in the "defense" healthcare sector, overall optimism is important for funding, but their growth depends more on successful marketing and prescription volumes.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Aytu BioPharma Inc.
Aytu BioPharma is a pharma company. They don't engage in R&D from scratch, but rather acquire (roll-up) FDA-approved niche drugs (primarily pediatric and prescription vitamins) and sell them. This chart is a summary indicator of their M&A strategy. It reflects their ability to manage this orphan portfolio and their (uphill) struggle for profitability and debt management.
AKIMA Market Segment Index - Specialized pharma
Aytu BioPharma (AYTU) is a diversified pharmaceutical company. They sell prescription medications (ADZENYS for ADHD) and also develop new drugs (for example, for rare diseases). The chart shows the average index for the segment, helping investors evaluate how effective this hybrid commercialization and R&D model is compared to the average.
The AKIM Index for the overall market
Aytu BioPharma is a pharmaceutical company commercializing a portfolio of pediatric (ADHD) and consumer health products. This chart, which reflects the market average, provides a macro backdrop. It helps assess how AYTU, focused on revenue growth and efficiency, compares to overall economic trends.
